Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study

Abstract

Although the overall diversity and structure of the gut microbiota did not differ between the MG, NIND and CIDP groups, the significant difference in the abundance of Deltaproteobacteria and <i>Faecalibacterium</i> supports the possible role of gut microbiota as a contributor to pathogenesis of MG. Further studies are needed to confirm these findings and to develop possible treatment strategies.